/C O R R E C T I O N — InstaMed® Pharmaceuticals/

/C O R R E C T I O N -- InstaMed® Pharmaceuticals/

PR Newswire

SALT LAKE CITY, July 27, 2026

In the news release, Biotech Innovator InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of Worldwide Launch of Non-Injectable Peptide Platform, issued 27-Jul-2026 by InstaMed® Pharmaceuticals over PR Newswire, we are advised by the company that a change has been made. The complete, corrected release follows:

Biotech Innovator InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of Worldwide Launch of Non-Injectable Peptide Platform